Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality.

Kevin M PantaloneJoyce GeorgeXinge JiMichael W KattanAlex MilinovichJanine M BaumanBartolome BurgueraRobert S ZimmermanAnita D Misra-Hebert

Published in: Basic and clinical andrology (2019)

In hypogonadal men with a modest prevalence of established CVD, TRT was not observed to confer a protective or adverse effect on the risk of MI, CVA or all-cause mortality.

Keyphrases

replacement therapy
smoking cessation
risk factors
cardiovascular events
adverse drug
middle aged
type diabetes
emergency department
coronary artery disease
electronic health record
drug induced